Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, covering all aspects of healthcare, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies, and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

Jul 20, 2017, 00:01 ET Commission The Lancet : un tiers de la démence pourrait être prévenue

- The Lancet publie la Commission internationale sur la prévention, le traitement et les soins relatifs à la démence - - Le NIA des États-Unis...


Jul 20, 2017, 00:01 ET Congreso® internacional 2017 se centrará en estilos de vida, reducir el riesgo, mejorar los diagnósticos y la detección precoz

Los resultados de un nuevo estudio sobre el Alzheimer fueron presentados en el Congreso Internacional de la Asociación para el Alzheimer 2017 (AAIC...


Jul 20, 2017, 00:01 ET Comisión The Lancet: un tercio de los casos de demencia podrían ser evitables

- The Lancet publica la Comisión Internacional sobre Prevención, Intervención y Cuidados de la Demencia - - El NIA de EEUU hace públicas las...


Jul 20, 2017, 00:01 ET International Conference® 2017 legt Schwerpunkt auf Lebensstil, Risikominderung, bessere Diagnose und Früherkennung

Neue Forschungsergebnisse, die auf der Alzheimer's Association International Conference 2017 (AAIC 2017) präsentiert wurden, vertiefen unser...


Jul 19, 2017, 16:30 ET VolitionRx Limited to host a conference call regarding a 13,500 Subject Colorectal Cancer Screening Trial with the Early Detection Research Network of the U.S. National Cancer Institute

VolitionRx Limited (Volition; NYSE MKT: VNRX), announced it will host a conference call tomorrow, July 20 at 8:30 AM U.S. Eastern Time to discuss...


Jul 19, 2017, 16:25 ET Theravance Biopharma and Mylan Announce Positive Results from 12-Month Phase 3 Safety Study of Revefenacin (TD-4208) in Patients with Chronic Obstructive Pulmonary Disease (COPD)

Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma") and Mylan N.V. (NASDAQ, TASE: MYL) ("Mylan") today announced positive results...


Jul 19, 2017, 16:25 ET Theravance Biopharma and Mylan Announce Positive Results from 12-Month Phase 3 Safety Study of Revefenacin (TD-4208) in Patients with Chronic Obstructive Pulmonary Disease (COPD)

Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma") and Mylan N.V. (NASDAQ, TASE: MYL) ("Mylan") today announced positive results...


Jul 19, 2017, 16:20 ET Rosalind Franklin University receives NIH funding for breakthrough research on neurological repair: $2.8 million grant supports collaboration with German research institute

A $2.8 million grant from the National Institutes of Health (NIH) will help researchers at Rosalind Franklin University of Medicine and Science...


Jul 19, 2017, 14:00 ET AI That Sees the Invisible: AliveCor and Mayo Clinic Announce Collaboration to Develop Groundbreaking AI Technology to Help Prevent Sudden Cardiac Death

AliveCor, the leader in FDA-cleared personal electrocardiogram (ECG) technology, today announced a collaboration with Mayo Clinic to...


Jul 19, 2017, 13:33 ET Piramal Imaging Applauds Interim Results and Reiterates Support of IDEAS Trial in Mild Cognitive Impairment (MCI) and Atypical Dementia

Trial Led by Alzheimer's Association and American College of Radiology Evaluating Impact of Brain Amyloid PET Imaging on Patient Management and...


Jul 19, 2017, 11:16 ET Neurotrope Presents Phase 2 Data Assessing Bryostatin-1 in Moderate-to-Severe Alzheimer's Patients at AAIC 2017

Neurotrope, Inc. (NASDAQ: NTRP) today presented clinical results from its recently completed Phase 2 trial demonstrating that moderate-to-severe...


Jul 19, 2017, 10:11 ET Evolus Announces FDA Acceptance for Review of the Biologics License Application for DWP-450 Neuromodulator

Evolus Inc. (www.Evolus.com) received confirmation from the U.S. Food and Drug Administration (FDA) that their Biologics License Application (BLA)...


Jul 19, 2017, 09:00 ET The Leukemia & Lymphoma Society (LLS) Announces Expansion of Groundbreaking Precision Medicine Approach to Fight Deadly Blood Cancer

The Leukemia & Lymphoma Society (LLS) today announced the expansion of its groundbreaking precision medicine Beat AML® Master Trial, to test...


Jul 19, 2017, 09:00 ET Imago BioSciences Doses First Patients in the Phase 2a Portion of the Study of IMG-7289 in Acute Myeloid Leukemia and Myelodysplastic Syndrome

Imago BioSciences, a clinical-stage pharmaceutical company developing novel anti-cancer therapies, announced today that the first patients have...


Jul 19, 2017, 08:45 ET Medic Vision Granted US Patent for its XR-29 Solution

Medic Vision, the pioneer and US market leader in 3rd party XR-29 standard solutions, announced today that it was granted a patent by the US...


Jul 19, 2017, 08:00 ET Intec Pharma Granted Patent in Hong Kong for Accordion Pill™ Carbidopa / Levodopa

Intec Pharma Ltd. (NASDAQ, TASE: NTEC), a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion...


Jul 19, 2017, 08:00 ET Bioniz Therapeutics Reports Top-Line Phase 1 Clinical Study Results for BNZ-1, A Novel Multi-Cytokine Inhibitor

Bioniz Therapeutics, Inc., a clinical stage biopharmaceutical company leading the discovery and development of first-in-class peptide therapeutics...


Jul 19, 2017, 08:00 ET New Preclinical Data for Intepirdine Suggests Potential Neuroprotective Properties

Axovant Sciences (NYSE: AXON) today announced new data from a preclinical study which suggests that intepirdine may have neuroprotective properties...


Jul 19, 2017, 07:00 ET AcelRx Pharmaceuticals Appoints Raffi Asadorian as Chief Financial Officer

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...


Jul 19, 2017, 06:19 ET Los datos de Zebinix® (acetato de eslicarbazepina) demuestran ausencia de consecuencias negativas significativas en la función neurocognitiva en niños con epilepsia focal

- El acetato de eslicarbazepina ha demostrado no presentar consecuencias negativas significativas en la atención, el procesamiento de...


Jul 19, 2017, 06:03 ET I primi risultati del registro GARFIELD-VTE presentati al congresso ISTH 2017 hanno fatto luce su una vasta eterogeneità di pazienti VTE nel mondo, sulle loro cure ed esiti

- Forte di criteri unici ampiamente inclusivi, il registro copre diverse popolazioni di pazienti con VTE in una serie di luoghi di cura e...


Jul 19, 2017, 05:56 ET OMICS International y el sistema abierto de revisión científica externa y de posrevisión científica externa

- El sistema abierto de revisión científica externa y de posrevisión científica externa: los nuevos criterios de las futuras publicaciones...


Jul 19, 2017, 05:00 ET EIP Pharma announces presentation of new mechanism of action data regarding neflamapimod (VX-745) at Alzheimer's Association International Conference (AAIC)

EIP Pharma, LLC (www.eippharma.com) today announced that new mechanism of action data regarding neflamapimod were presented at the AAIC 2017...